Trials / Conditions / HR Positive/HER-2 Negative Breast Cancer
HR Positive/HER-2 Negative Breast Cancer
4 registered clinical trials studyying HR Positive/HER-2 Negative Breast Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer NCT07102940 | George Washington University | Phase 2 |
| Not Yet Recruiting | A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors NCT07383506 | Cogent Biosciences, Inc. | Phase 1 |
| Recruiting | Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Brea NCT07211178 | Tempus AI | — |
| Unknown | A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Neg NCT06172322 | Nanjing Chia-tai Tianqing Pharmaceutical | Phase 1 |